Juvenile myelomonocytic leukaemia

Emad Uddin Siddiqui, Shaheena Hanif

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Juvenile Myelomonocytic Leukemia (JMML) is a rare hematopoietic malignancy of early childhood. Infection remains the principal cause of death in patients with myelodysplastic syndrome (MDS). Sixty percent of patients are anemic and 26 percent have petechiae and/or purpura (thrombocytopenia). Bone Marrow Transplant (BMT) is the best available treatment option. We describe the management of an eight months old male child who presented with complaints of fever, cough and pallor since six months. Despite medication his fever did not subside. He developed meningitis and intracranial bleed and expired on 11 th day of hospitalization.

Original languageEnglish
Pages (from-to)175-177
Number of pages3
JournalPakistan Journal of Medical Sciences
Issue number1
Publication statusPublished - Jan 2008
Externally publishedYes


  • Juvenile Myelomonocytic Leukaemia


Dive into the research topics of 'Juvenile myelomonocytic leukaemia'. Together they form a unique fingerprint.

Cite this